Sunday, August 2, 2020

Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...

from NDTV News - India-news https://ift.tt/2XmSgN8

No comments:

Post a Comment

'To not offend anti-Hindu haters': Indian-origin brand removes Laxmi idol from packaging, faces immense flak online

from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/5ANoqJM via IFTTT